scorecardresearch
Add as a preferred source on Google
Saturday, February 21, 2026
TopicCipla

Topic: Cipla

New injectable to treat complex, antibiotic-resistant UTIs now in India. All about plazomicin

Prevalence of UTIs in Indian population is estimated to be around 33%. Men have less than 15% chance of developing this infection in their lifetime compared to 60% in case of women.

Cipla set to bring Afrezza, 1st inhalable insulin since Exubera, to Indian markets by 2025

Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, received CDSCO approval this week.

Who is Jasdeep Singh Gill, new spiritual head of Punjab’s powerful Dera Beas

An IIT Delhi and Cambridge alumnus, Gill will take over from Gurinder Singh Dhillon. Dera Radha Soami Satsang Beas wields significant influence in Punjab.

Cipla’s US unit recalls 6 bronchospasm inhaler batches over container defect

Cipla advises consumers to discontinue use, return or discard the inhalers, and report any adverse reactions to the U.S. health agency.

Godrej, Cipla, Tata— private archives are filling the gaps in the story of modern India

The National Archives of India has almost no record of India's Green Revolution but National Centre for Biological Sciences in Bangalore does.

Using ‘4IR’ tech to beat global challenges — why 4 Indian firms are on WEF’s ‘lighthouses’ list

Cipla, Dr Reddy’s Lab, Mondelez & Unilever lauded for transition to fourth industrial revolution using advanced technologies despite global challenges like Ukraine war & Covid.

Drugmaker Cipla eyes acquisitions in India, US after Covid windfall

Cipla says it's open to mergers & acquisitions. It may partner with smaller firms working on mRNA platforms after the technology came to the fore during the pandemic.

Only boycott of British goods won’t do — Why Abdul Hamied went on to create Cipla

In 'Caring For Life: The Cipla Story Since 1935', Tulsi Vatsal writes about how Khwaja Abdul Hamied wanted to create a science-based industry for India.

Cipla to experiment with Covid drug remdesivir composition to reduce effect on kidneys

Government's subject expert committee asks Cipla to assess renal toxicity of remdesivir's new formulation through a bioequivalence study as well as clinical trials.

India could be producing over 20,000 vials of Remdesivir per day by month-end: Govt data

Remdesivir is now being manufactured by Cipla, Hetero Labs and Mylan. Cipla Wednesday launched the drug under the brand name Cipremi.

On Camera

Youth Congress, your foolish protest helped the Modi govt climb out of the AI summit hole

In tactical terms, the shirtless protest was worse than a self-goal. Suddenly, the fiascos of the AI Summit were forgotten, and the Youth Congress’s disruption became the issue.

In the West, there’s anxiety. In India, optimism—Rishi Sunak says India poised to be leader in AI

On Wednesday, the former UK Prime Minister Rishi Sunak was speaking in New Delhi at a Carnegie & Observer Research Foundation event on AI.

MoD, IAF agree on some exemptions to HAL for Tejas Mk1A, but no compromise on ‘must-have’ capabilities

IAF is fine with accepting the aircraft with 'must-haves', even if some other steps remain pending, which may take at least another year, it is learnt.

No country is ever fully sovereign. Cold War era taught India its real meaning

India’s fraught neighbourhood places multiple constraints on its strategic choices. It leaves no time to take a deep breath, lean back and reset.